A Comparative Controlled Trial of Methotrimeprazine (“Veractil”) in Chronic Schizophrenia

Abstract

Despite the good results reported in recent years in many cases of chronic schizophrenia following the use of tranquillizing drugs, there remains in mental hospitals a group of chronic and often deteriorated patients who have shown a strong resistance to all forms of treatment. In many such cases disturbances of behaviour are modified and sometimes controlled by such drugs as chlorpromazine and reserpine. Nevertheless, the overall situation is far from satisfactory and the search for more effective drugs continues.